AML3D reports 70% revenue growth as ARCEMY expands beyond US defence
AML3D Limited, Adelaide, Australia, has reported revenue, including lease income, of $12.5 million for the financial year ended June 30, 2026 (FY26), an increase of 70% on the prior corresponding period. The company also recorded its first EBITDA-profitable half-year.
AML3D’s order book peaked at $29 million during FY26, comprising $20 million in new orders and $9 million carried forward from the previous year. In the second half of FY26, from January 1–June 30, 2026, the company recorded its first half-year EBITDA profit of $608,000.
The company attributed its FY26 performance to demand for its ARCEMY metal Additive Manufacturing technology in the US defence sector, particularly within the US Navy’s Maritime Industrial Base (MIB).
Since beginning its activity in this market in 2023, AML3D has signed contracts to deploy fourteen ARCEMY machines into the US Navy supply chain, as well as receiving two further machine orders for US industrial manufacturing applications.
During FY26, AML3D also signed a $2.6 million contract to supply high-demand, non-safety-critical replacement components used in US Navy submarines. As of June 30, 2026, the company had $16.8 million of contracted work and an estimated global sales pipeline of $78 million.
Diversification strategy
AML3D continues to deploy its ARCEMY technology within the US Navy MIB supply chain while targeting other sectors and international defence markets.
During FY26, following a competitive tender process, AML3D deployed its first ARCEMY machine to the US utility sector to support the Tennessee Valley Authority’s (TVA) power generation repair fleet.
AML3D also deployed its first ARCEMY machine to US industrial manufacturer FasTech, which manufactures and supplies parts for the defence, aerospace, energy and other sectors.
The company also entered the UK defence market during FY26. AML3D progressed its material feasibility programme for BAE Systems in the UK and agreed distribution deals covering the UK and Europe.
AML3D now has defence relationships in all three AUKUS countries: Australia, the UK and the US.
Outlook
At June 30, 2026, AML3D had a cash balance of $26.8 million. The company plans to continue a $12 million investment to double its US capacity and support US defence and industrial manufacturing demand in FY27.
AML3D also plans to invest $5 million in a UK Technology Centre to support demand in the UK and Europe.
In Australia, the company plans to finalise a $2.24 million programme to develop advanced manufacturing technology. It has also completed the establishment of a manufacturing base to support AUKUS demand and has been onboarded to the AUKUS Vendor Qualification (DIVQ) Program.
“The 2026 financial year saw rapid growth in ARCEMY system installations and component manufacturing in the USA. It is encouraging to see our strategy of moving beyond the US Defence market begin to gain traction,” stated Sean Ebert, AML3D Managing Director. “During the year, we achieved record revenue growth and delivered our first profitable half-year in the second six months.”
“Demand that supported our FY26 performance has continued into FY27. While we continue to deliver the $16.8 million orders in hand, we are also working to convert our $78 million global sales pipeline and have visibility on potential near-term contracts in the US and the UK. Our strong balance sheet means we have the capacity to complete our planned $17 million investment to double US manufacturing capacity and establish a European Technology Centre to support growth. We are focused on continuing AML3D’s multi-year track record of record delivery and building shareholder value over time,” Ebert concluded.
